Medtronic (NYSE:MDT) said today it enrolled the 1st patient in a clinical study of its Valiant TAAA stent graft system designed as a minimally invasive treatment for thoracoabdominal aortic aneurysm. The Valiant TAAA stent graft system is designed to operate as an off-the-shelf endovascular solution for patients suffering from aortic aneurysms, which are dangerous bulging or […]
Stent Grafts
Appeals court reverses TriReme patent loss to AngioScore
CORRECTED July 22, 2016. This article originally transposed the patent infringement lawsuit filed by TriReme against AngioScore for a breach-of-contract lawsuit filed by AngioScore. A federal appeals court today reversed a lower court’s patent infringement ruling that went against TriReme Medical and a pair of related companies in favor of AngioScore, sending the case back to a lower court […]
Endologix, TriVascular Technologies close $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) said yesterday that they closed their $221 million merger, uniting 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while Santa Rosa, Calif.-based TriVascular makes the Ovation stent graft. “The completion […]
PAD: Gore launches post-approval study of Viabahn stent graft
W.L. Gore & Associates said this week that it launched a post-approval study of its Viabahn stent graft for treating peripheral artery disease. The 108-patient Reline Max study will examine the treatment of in-stent restenosis in the superficial femoral artery using the Viabahn device, which is designed to inhibit blood clots with its heparin coating. The Viabahn […]
Gore wins round in stent graft bout with Bard
W.L. Gore & Associates won a round against C.R. Bard (NYSE:BCR) in an ongoing stent graft patent validity battle as a Delaware federal judge upheld the validity of 2 Gore stent graft patents. The court ruled that Gore’s patent on stent graft devices in tubes less than 0.1 millimeter was valid, rejecting Bard’s invalidity argument, […]
Cordis touts 4-year data on Incraft AAA stent graft
Cordis Corp. said today that 4-year data from a trial of its Incraft abdominal aortic aneurysm stent graft system showed it “performed well” in patients suffering from AAAs 4 years after treatment. Data from the study was presented at the VEITHsymposium in New York City this week. The multi-center, open-label prospective Innovation trial reported a 97% […]
Endologix, TriVascular clear U.S. regulatory hurdle in $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said that the waiting period set by U.S. anti-trust laws for their $211 million merger ended early, setting the stage for the deal to close during the 1st quarter next year. The companies said the U.S. Federal Trade Commission and Justice Dept. granted early termination of the waiting period under […]
Medtronic touts Endurant AAA graft 4-year data
Medtronic (NYSE:MDT) said today that 4-year real world data from a subset of patients with challenging anatomy implanted with the Endurant AAA stent graft system showed durable outcomes. The data was presented at the VEITHsymposium in New York City. At 4-years, no differences in IA endoleak rate or AAA diameter increases were found between subsets of […]
Medtronic, Hansen to present clinical trial data at VEITHSymposium
Medtronic (NYSE:MDT) and Hansen Medical (NSDQ:HNSN) said they are slated to present new clinical information at this year’s annual VEITHSymposium in New York City. Medtronic said today it plans to present 4-year subset data results from the ENGAGE global registry study of its Endurant AAA stent graft system. The trial analyzed patients with hostile neck anatomies treated with […]
Endologix, TriVascular Technologies ink $211m merger
Endologix (NSDQ:ELGX) and TriVascular Technologies (NSDQ:TRIV) yesterday said they plan to merge in a cash-and-stock deal worth $211 million. If consummated, the deal would unite 2 of the stent graft market’s smaller players. Both companies makes devices for treating abdominal aortic aneurysms; Irvine, Calif.-based Endologix makes 2 lines of stent grants, the Nellix and AFX devices, while […]
TCT 2015 Roundup: Edwards presents early Forma tricuspid repair results
Edwards Lifesciences (NYSE:EW) said yesterday that data from the 1st 13 uses of its Forma transcatheter tricuspid repair system reported no deaths or major complications. The announcement was made at the annual Transcatheter Cardiovascular Therapeutics conference in San Francisco and data from the 1st 7 patients was published in the Journal of the American College of […]